DEA Must Consult FDA On Psilocybin Petition, 9th Circ. Told
A Seattle physician seeking to loosen restrictions on psilocybin, the active ingredient in psychedelic mushrooms, has asked the Ninth Circuit for a new order requiring the Drug Enforcement Administration to refer...To view the full article, register now.
Already a subscriber? Click here to view full article